1-3 of 3
Sabine Chlosta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

Clinical Trials & Observations Brief Report
Pier Luigi Zinzani, Vincent Ribrag, Craig H. Moskowitz, Jean-Marie Michot, John Kuruvilla, Arun Balakumaran, Yayan Zhang, Sabine Chlosta, Margaret A. Shipp, Philippe Armand
Journal: Blood
Blood (2017) 130 (3): 267–270.
https://doi.org/10.1182/blood-2016-12-758383
Published: 2017
Includes: Supplemental data
Journal Articles

Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial

Pier Luigi Zinzani, MD PhD, Vincent Ribrag, MD, Craig H. Moskowitz, MD, Jean-Marie Michot, MD, John Kuruvilla, MD, Arun Balakumaran, MD PhD SM, Yayan Zhang, PhD, Patricia Marinello, PharmD, Sabine Chlosta, MD, Eric Gustafson, PhD, Margaret A. Shipp, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2016) 128 (22): 619.
https://doi.org/10.1182/blood.V128.22.619.619
Published: 2016
Journal Articles

Pembrolizumab, a PD-1 Inhibitor, in Patients with Myelodysplastic Syndrome (MDS) after Failure of Hypomethylating Agent Treatment

Guillermo Garcia-Manero, MD, Martin S. Tallman, MD, Giovanni Martinelli, MD, Vincent Ribrag, MD, Hui Yang, MD PhD, Arun Balakumaran, MD PhD SM, Sabine Chlosta, MD, Yayan Zhang, PhD, B. Douglas Smith, MD
Journal: Blood
Blood (2016) 128 (22): 345.
https://doi.org/10.1182/blood.V128.22.345.345
Published: 2016